Modern Diagnostic IPO GMP: Day 1 IPO Live Updates
Posted by : sachet | Wed Dec 31 2025
The Modern Diagnostic IPO GMP is ₹10 as of 31st December 2025. It is a book-building issue IPO of ₹36.89 crores. This is an entirely fresh issue of 0.41 crore shares. The issue will be listed on BSE and SME on its tentative listing date, 7th January 2026. The face value of Modern Diagnostic IPO shares is ₹10 per share, and the IPO price band is ₹85 to ₹90 per share. Retail investors can bid for a minimum of 2 lots of 3,200 shares worth ₹2,88,000
Modern Diagnostic IPO GMP Grey Market Premium
As mentioned earlier, the Modern Diagnostic IPO GMP currently stands at ₹10.00 per share. Thus, the estimated listing price would be at ₹100. This indicates that the estimated listing gain in this IPO could be 11.11%. Explore the table for Modern Diagnostic IPO GMP updates.
| GMP DATE | IPO Price | GMP Price | Estimated Listing Price | Estimated Gain |
| 31-12-2025 | ₹90 | ₹10 | ₹100 | 11.11% |
| 30-12-2025 | ₹90 | ₹10 | ₹100 | 11.11% |
| 29-12-2025 | ₹0.00 | ₹0.00 | ₹0.00 | 0.00% |
| 28-12-2025 | ₹0.00 | ₹0.00 | ₹0.00 | 0.00% |
| 27-12-2025 | ₹0.00 | ₹0.00 | ₹0.00 | 0.00% |
| 26-12-2025 | ₹0.00 | ₹0.00 | ₹0.00 | 0.00% |
Note: GMP details are subject to change based on market conditions and fluctuations. Check live Modern Diagnostic IPO GMP status at Univest.
Modern Diagnostic IPO Details
| IPO Allotment Date | 5th January 2026 |
| IPO Open Date | 31st December 2025 |
| IPO Close Date | 2nd January 2026 |
| Refund Initiation | 6th January 2026 |
| Issue Size | 40,99,200 shares(agg. up to ₹37 Cr) |
| Face Value | ₹10 per share |
| Lot Size | 1,600 Shares |
| Issue Price | ₹85 to ₹90 per share |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE & SME |
| Listing Date | 7th January 2026 |
Also Read: Modern Diagnostic IPO GMP & Review: Apply or Avoid?
Explanation
Modern Diagnostic IPO: Modern Diagnostic IPO Limited has declared an issue price band of ₹85 to ₹90 per share. With this IPO, the company allows retail investors to bid for at least 2 lots of 3,200 shares, each worth ₹2,88,000. The face value of Modern Diagnostic IPO Limited shares is ₹10 per share. The shares of Modern Diagnostic IPO Limited will be listed on BSE and SME on its tentative listing day, 7th January 2026. Scroll down to check GMP updates and Modern Diagnostic IPO reviews.
Modern Diagnostic IPO Objectives
The primary aim of the Modern Diagnostic IPO is to raise ₹36.89 crores. On the other hand, Modern Diagnostic has decided to utilise these funds in different ways.
- To meet working capital requirements
- To General Corporate Purpose
Modern Diagnostic IPO Registrar
MUFG Intime India Private Limited is the registrar for the Modern Diagnostic IPO, awaiting to manage the allotment process and initiate refunds. For any queries regarding the Modern Diagnostic allotment and refund, you can contact MUFG Intime India Private Limited at moderndiagnostic.smeipo@in.mpms.mufg.com or at +91-22-4918 6270.
Modern Diagnostic IPO Review
The Modern Diagnostic IPO has gained neutral ratings from industry experts, brokers, and institutional investors. Modern Diagnostic & Research Centre Ltd.’s revenue increased by 15% and profit after tax (PAT) rose by 55% between the financial year ending with March 31, 2025 and March 31, 2024.
Most analysts recommend applying for this IPO to diversify your investment portfolio. However, we’re waiting for additional ratings to get a clearer picture and will keep posting them to deliver real-time insights. Until then, you can explore the company’s technical analysis to know whether you should apply for the Modern Diagnostic IPO or not.
| Key Indicators | Value |
| PE Ratio (Price-to-Earnings) | 11.04 |
| EPS (Earnings Per Share) | 8.15 |
| RoNW | 43.27% |
| ROCE | 36.18% |
| ROE | 55.21% |
| EBITDA Margin | 23.04% |
| Price to Book Value | 4.78 |
| Market Capitalisation | ₹136.00 Cr |
The PE ratio of Modern Diagnostic Limited shares is 11.04, and its Earnings Per Share (EPS) stands at 8.15. Thus, the Modern Diagnostic IPO can deliver gains on its tentative listing date, 7th January 2026.
Note: The data, as mentioned above, is taken from authentic sources and highlights pre-issue information. The PE ratio and EPS of Modern Diagnostic Limited are subject to change after the IPO. Explore the table below to get post-issue updates on these two metrics.
| Indicators | Pre-IPO | Post-IPO |
| PE Ratio | 11.04 | – |
| EPS | 8.04 | – |
FAQs on Modern Diagnostic IPO
What is the Modern Diagnostic IPO GMP?
Currently, on 31st December 2025, the Modern Diagnostic IPO GMP (Grey Market Premium) stands at ₹10. This indicates that the estimated listing price could be ₹100.00 per share.
What is the issue price of Modern Diagnostic IPO?
The Modern Diagnostic IPO issue price band is set at ₹85.00 to ₹90.00 per share. Retail investors can apply for a minimum of 2 lots, each consisting of 3,200 shares, worth ₹2,88,000. Moreover, HNIs are required to bid for a minimum of 3 lots (4,800 shares) worth ₹4,32,000.
Who is the registrar of the Modern Diagnostic IPO?
MUFG Intime India Private Limited is the registrar for the Modern Diagnostic IPO, awaiting to manage the allotment process and initiate refunds. For any queries regarding the Modern Diagnostic allotment and refund, you can contact MUFG Intime India Private Limited at moderndiagnostic.smeipo@in.mpms.mufg.com or at +91-22-4918 6270.
Disclaimer: The above information is compiled from authentic sources and is just for informational purposes. To have detailed information about the Modern Diagnostic IPO, download the Modern Diagnostic IPO RHP and Modern Diagnostic IPO DRHP. Conduct your research before investing in IPOs to avoid significant losses. You can also consult your financial advisor.
Recent Articles
Ravelcare IPO GMP: Day 3 IPO Live Updates
Astron Multigrain IPO Subscription Day 2
Astron Multigrain IPO GMP: Day 2 IPO Live Updates
